- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00760903
Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma
The purpose of this study is to use magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI) to assess for traumatic brain injury and determine if there is any correlation of these findings to clinical outcome. MR spectroscopy using 2D-CSI (a multi voxel technique) of the corpus callosum, basal ganglia, lobar white matter and brainstem may reveal areas of injury and quantification of the metabolites from these areas may be used to correlate with imaging findings and clinical evaluation. White matter disruption in these areas is commonly seen after TBI, caused by diffuse axonal injury. It has been implicated in the long term outcomes in these patients, but has been difficult to assess by standard radiologic studies.
By the use of DTI it may be possible to demonstrate damaged white matter tracts which could be helpful in the evaluation of traumatic brain injury. Most TBI subjects have injuries that involved torque to the brain. This results in a shearing injury to the long white matter tracts, which has been hypothesized to be related to cognitive outcome.
Also, to demonstrate that MRS and DTI prove valuable in predicting outcome in patients of moderate brain trauma by conducting progressive studies acutely (within 24 hours) and long term (4-6 weeks). Most patients will most likely be followed clinically for over a year, and, if clinical indicated, farther scanning can be done at a later date.
By comparing fraction anisotropy, ADC values, and metabolic ratios by the use of DTI and MRS in the adult and pediatric populations, may help to assess differences in recovery.
Lastly, a comparison between the two groups in changes in brain metabolism and/or white matter tract disruption/re-connection after TBI with and/or without links to outcome can be done.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients of acute moderate brain trauma
Exclusion Criteria:
Patients who are medically unstable or have CT findings that may interfere with the study such as:
- a large hemorrhage or edema
- encephalomalacia
- prior neurosurgeries
- hardware placed in the head or neck
- prior head trauma
- history of neurological conditions
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
> 18 years moderate head trauma
Group I: (Pilot group): 5-10 patients > 18 years old, gender and race indifferent with moderate head trauma.
|
|
|
> 18, gender and race indifferent
Group II: 30 patients > 18 years old, gender, and race indifferent with moderate head trauma
|
|
|
Pediatric
Group III: 30 patients < 18 years old, gender and race indifferent with moderate head trauma (pediatric patient group)
|
|
|
Pre-evaluated
Group IV: 10-20 patients age, gender and race indifferent with moderate head trauma that have been examined with conventional MRI of the brain, MRS and DTI as clinically requested.
The images of these patients will be evaluated retrospectively for data- point collection.
|
|
|
Control Group
Group V (control group): 20 volunteers without prior history of traumatic brain injury or neurological problems.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To determine if MRI imaging can accurately detect the clinical outcome (extent of recovery) of patients who have moderate to severe brain injury.
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2003-0053
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Trauma
-
Università degli Studi dell'InsubriaUnknownSevere Brain TraumaItaly
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedBrain Injuries | Brain Injuries, Traumatic | Traumatic Brain Injury | Trauma, Brain | Brain, TraumaUnited States
-
Tanta UniversityRecruiting
-
Australian and New Zealand Intensive Care Research...Recruiting
-
Peter SiesjöUniversity of StellenboschCompleted
-
University Hospital, GrenobleUnknown
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaboratorsCompletedBrain Injury | Craniocerebral Trauma | Trauma Nervous SystemFrance
-
University of Kansas Medical CenterCompleted
Clinical Trials on Conventional MRI of the brain
-
University Hospital, MontpellierNovartisTerminatedParkinson's Disease | Multiple System Atrophy | Progressive Supranuclear Palsy | Vascular ParkinsonismFrance
-
Loma Linda UniversityCompletedCerebrovascular Disorders | Brain InjuriesUnited States
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBrain TumorsUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingStatus Epilepticus | Positron-emission Tomography | Ictal-interictal Continuum | Perfusion Weighted MRI | Perfusion CTBelgium
-
NYU Langone HealthWithdrawn
-
Northwell HealthNational Institutes of Health (NIH)RecruitingElectroconvulsive Therapy Treated PatientsUnited States
-
Nationwide Children's HospitalSanfilippo Children's Research Foundation; The Sanfilippo Research Foundation; The Children's Medical Research FoundationCompletedMucopolysaccharidosis Type IIIA | Mucopolysaccharidosis Type IIIBUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingMSA - Multiple System Atrophy | Dementia With Lewy Bodies (DLB) | Alzheimer Dementia (AD) | PSP - Progressive Supranuclear Palsy | ALS With Frontotemporal Dementia (ALS/FTD) | Parkinson s Disease | REM Sleep Behavior Disorder (iRBD) | ALS - Amyotrophic Lateral Sclerosis | Adult Onset Psychotic Disorder and other conditionsBelgium
-
Lille Catholic UniversitySSR pédiatrique Marc SauteletCompletedAdolescent Idiopathic ScoliosisFrance